Karyopharm Therapeutics | 4:持股变动声明-高管 Paulson Richard A.
Karyopharm Therapeutics | 4:持股变动声明-高管 Rangwala Reshma
Karyopharm Therapeutics | 4:持股变动声明-高管 Paulson Richard A.
Karyopharm Therapeutics | 4:持股变动声明-高管 Paulson Richard A.
Karyopharm Therapeutics | 4:持股变动声明-高管 Rangwala Reshma
Karyopharm Therapeutics | 4:持股变动声明-高管 Poulton Stuart
Karyopharm Therapeutics | 4:持股变动声明-高管 Mason Michael
Karyopharm Therapeutics | 4:持股变动声明-高管 Mano Michael
Karyopharm Therapeutics | 4:持股变动声明-高管 Cheng Sohanya Roshan
Karyopharm Therapeutics | 4:持股变动声明-高管 Paulson Richard A.
Karyopharm Therapeutics | 4:持股变动声明-高管 Mano Michael
Karyopharm Therapeutics | 4:持股变动声明-高管 Mason Michael
Karyopharm Therapeutics | 4:持股变动声明-高管 Poulton Stuart
Karyopharm Therapeutics | 4:持股变动声明-高管 Rangwala Reshma
Karyopharm Therapeutics | 4:持股变动声明-高管 Cheng Sohanya Roshan
Karyopharm Therapeutics | 4:持股变动声明-高管 Paulson Richard A.
Karyopharm Therapeutics | 4:持股变动声明-高管 Poulton Stuart
Karyopharm Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
Karyopharm Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Avidity Partners Management LP(9.5%),Avidity Partners Management (GP) LLC(9.5%)等
Karyopharm Therapeutics | SC 13G:超过5%持股股东披露文件-The Vanguard Group(7.60%)
暂无数据